Other Infections
CROI 2011: Immediate ART Improves Survival for HIV+ People with TB
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 22 March 2011 00:00
- Written by Liz Highleyman
Tuberculosis patients who immediately start antiretroviral therapy are less likely to progress to AIDS or die, but among people with higher CD4 counts, waiting reduces the risk of IRIS, researchers reported at CROI 2011. 
March 24 is World TB Day
- Details
- Category: Tuberculosis (TB)
- Published on Monday, 21 March 2011 17:00
- Written by NIAID
Thursday, March 24, is designated as World TB Day, calling attention to a disease that is a major killer worldwide, especially of people with HIV/AIDS.
Prevention Task Force Recommends Wider Bone Screening for Older Women
- Details
- Category: Bone Loss
- Published on Friday, 21 January 2011 23:50
- Written by HIVandHepatitis.com
The U.S. Preventive Services Task Force (USPSTF) this week issued revised guidelines, published in the January 17, 2011, advance online edition of Annals of Internal Medicine, recommending that all women age 65 and older should be screened for bone loss, along with younger women -- and presumably men -- who have equivalent risk. HIV and its treatment may raise the likelihood of bone loss, and experts recently recommended earlier bone screening for HIV positive women and men.
New Data on Mouse Retroviruses Link to Prostate Cancer, Chronic Fatigue Syndrome
- Details
- Category: XMRV & Other Retroviruses
- Published on Monday, 07 March 2011 13:17
- Written by Liz Highleyman
A set of studies published in the November 15, 2010 Journal of Infectious Diseases shed further light on associations between murine or mouse retroviruses and human disease. One study found xenotropic murine leukemia virus-related virus (XMRV) in normal and tumor tissue from men with prostate cancer. Two other studies in the same issue, however, did not see evidence of XMRV in people with chronic fatigue syndrome (CFS), blood-borne infections, or chronic immune suppression or activation, conflicting with prior findings. Experts urge more rigorous research and consistent methodology to help resolve such inconsistencies across studies.
Gardasil HPV Vaccine Approved for Anal Cancer
- Details
- Category: Human Papillomavirus (HPV)
- Published on Friday, 07 January 2011 12:55
- Written by FDA
On December 22, 2010, the U.S. Food and Drug Administration (FDA) approved the use of Merck's quadrivalent human papillomavirus (HPV) vaccine, Gardasil, for prevention of anal cancer in men and women age 9-26 years. The vaccine -- which targets high-risk HPV types 6, 11, 16, and 18 -- was previously approved for prevention of cervical cancer in young women.
New Vaccine May Be More Effective against Tuberculosis
- Details
- Category: Tuberculosis (TB)
- Published on Friday, 25 February 2011 01:57
- Written by Liz Highleyman
A new vaccine known as H56 promotes CD4 T-cell response and may be more effective in preventing tuberculosis than the widely used BCG vaccine, according to results from an international study published in the February 2011 issue of Nature Medicine. Experiments in mice showed that H56 vaccination conferred protective immunity and, if given after exposure to Mycobacterium tuberculosis, lowered the amount of bacteria and suppressed its reactivation.
First Case of Extremely Drug-resistant Tuberculosis in the U.S.
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 04 January 2011 17:17
- Written by Margie Mason & Martha Mendoza
Public health officials have identified the first case of extremely drug resistant tuberculosis, or XXDR-TB, in the U.S., according to a recent report by the Associated Press.
Oral Tenofovir Does Not Reduce Herpes Virus Shedding
- Details
- Category: Herpes
- Published on Tuesday, 25 January 2011 12:55
- Written by Liz Highleyman
HIV positive people who took tenofovir (Viread, also in the Truvada and Atripla combination pills) as part of their antiretroviral regimen were no less likely to shed herpes simplex virus 1 or 2 (HSV-1 or HSV-2) than individuals using non-tenofovir regimens, according to research described in the January 14, 2011, issue of AIDS. These findings are notable because a recent microbicide study found that a tenofovir gel reduced the likelihood of HSV-2 infection.
Tuberculosis Late Diagnosis and Mortality Decrease among HIV Positive People in U.S.
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 14 December 2010 13:17
- Written by Liz Highleyman
The rate of death due to tuberculosis (TB) in the U.S. has decreased by half since the early 1990s, mostly attributable to a reduction among HIV positive people, according to a study described in the November 26, 2010 Morbidity and Mortality Weekly Report. What's more, among people with HIV, the proportion who were not diagnosed with TB until after they died also declined, reflecting better access to medical care.
More Articles...
- More than 1 Million People Are Coinfected with HIV and Tuberculosis, WHO Report Says
- 2009 H1N1 Influenza: What Next for People with HIV?
- HIV Positive People May Need Triple Dose of Hepatitis A Vaccine
- Experimental Drug TMC207 Cuts Response Time for Multidrug-resistant Tuberculosis
- ICAAC 2010: Experimental Drug LMV-601 Inhibits HPV Replication and Abnormal Cell Growth in Laboratory Study
Web Design and Development by